TY - JOUR. T1 - Outcomes following surgical treatment compared to radiation for stage I NSCLC. T2 - A SEER database analysis. AU - Monirul Islam, K. M.. AU - Shostrom, Valerie. AU - Kessinger, Anne. AU - Ganti, Apar Kishor P. PY - 2013/10/1. Y1 - 2013/10/1. N2 - Introduction: Outcomes following surgery are better than following radiation therapy (RT), for stage I NSCLC. Whether this is due to selection of healthier patients for surgery is unclear. This study was undertaken to compare outcomes between surgical patients and patients who were surgical candidates but did not receive surgery. Methods: Data of patients with stage I NSCLC between 1988 and 2007, included in the SEER database were analyzed. Overall survival (OS) was examined by treatment type (surgery only, radiation only, surgery and radiation, and no treatment). OS was compared between RT patients who refused surgery and those not fit for surgery. Cox proportional hazards model was used to compare outcomes by treatment type. Results: ...
TY - JOUR. T1 - Distinct breast cancer incidence and prognostic patterns in the NCIs SEER program. T2 - Suggesting a possible link between etiology and outcome. AU - Anderson, William F.. AU - Jatoi, Ismail. AU - Devesa, Susan S.. PY - 2005/3/1. Y1 - 2005/3/1. N2 - Background. Breast cancer is a heterogeneous and chronic disease with relapses and death occurring 25 years or more after primary diagnosis. Standard tumor characteristics are used to predict initial relapse or death, but their ability to estimate long-term patterns of failure may be limited. Methods. To further evaluate the significance of standard tumor features, we compared incidence and prognostic patterns in the National Cancer Institutes (NCIs) large-scale population-based Surveillance, Epidemiology, and End Results (SEER) program for high-risk versus low-risk breast cancers, i.e., size ,2.0 versus ≤ 2.0 cm, lymph node positive versus negative, high versus low histologic grade, and hormone receptor negative versus positive ...
The National Cancer Institutes Surveillance, Epidemiology, and End Results (SEER) program The SEER program, a continuing project of the National Cancer Institute, collects cancer data on a routine basis from designated population-based cancer registries in various areas of the country. Trends in cancer incidence, mortality and patient survival in the United States, as well as many other studies, are derived from this data bank.. Goals of the SEER program are:. , Assembling and reporting, on a periodic basis, estimates of cancer incidence and mortality in the United States. , Monitoring annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. , Providing continuing information on changes over time in the extent of disease at diagnosis, trends in therapy, and associated changes in patient survival. , Promoting studies designed to identify factors amenable to cancer ...
The National Cancer Institutes Surveillance, Epidemiology, and End Results (SEER) program The SEER program, a continuing project of the National Cancer Institute, collects cancer data on a routine basis from designated population-based cancer registries in various areas of the country. Trends in cancer incidence, mortality and patient survival in the United States, as well as many other studies, are derived from this data bank.. Goals of the SEER program are:. , Assembling and reporting, on a periodic basis, estimates of cancer incidence and mortality in the United States. , Monitoring annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. , Providing continuing information on changes over time in the extent of disease at diagnosis, trends in therapy, and associated changes in patient survival. , Promoting studies designed to identify factors amenable to cancer ...
Lang, J. E., Summers, D. E., Cui, H., Carey, J. N., Viscusi, R. K., Hurst, C. A., Waer, A. L., Ley, M. L. B., Sener, S. F. and Vijayasekaran, A. (2013), Trends in post-mastectomy reconstruction: A SEER database analysis. J. Surg. Oncol., 108: 163-168. doi: 10.1002/jso.23365 ...
In the U.S., many cancers are also on the rise and, although smoking continues to decline, lung cancer rates in women are increasing. According to the U.S. National Cancer Institutes Surveillance Epidemiology & End Results (SEER) Database, 1 in 2 men will likely develop invasive cancer and 1 in 4 will likely die from cancer. For women, 1 in 3 will likely develop cancer and 1 in 5 will likely die from cancer. To us, this is not acceptable. But,what if…?. Imagine if cancer wasnt an inevitable disease, but rather something to be prevented through lifestyle choices and education. What if we can make a difference by changing our personal sustainability, that is, our daily choices regarding what we ingest, what we think and what we do? What if we can metabolically transform our bodies to live longer, healthier and happier? What if we can cause government to address laws regarding environmental toxins and their regulation? What if the cure, was simply … prevention?. The latest findings are that ...
Findings identify an effective alternative to traditional treatment methods. Research published in Februarys edition of the Journal of Thoracic Oncology investigates the utilization of surgery and the subsequent need for radiotherapy (RT) when treating stage I small cell lung cancer (SCLC). Traditionally, SCLC treatment regimes include chemotherapy and radiotherapy for limited stage disease; however, the study concludes that in selected patients with early stage disease a lobectomy (removal of lung) had an excellent overall survival without additional treatment.. Researchers retrospectively evaluated the outcomes of 247 stage I SCLC patients who underwent lobectomies; these cases were identified using the National Cancer Institutes Surveillance Epidemiology and End Results (SEER) database. Results showed the three- and five-year survival rates for the patient group who underwent lobectomies without RT were 58.1 percent and 50.3 percent, respectively. For those who supplemented their surgery ...
This Guide to Statistics and Methods summarizes the Surveillance, Epidemiology, and End Results data sets, including longitudinal details, included and excluded
TY - JOUR. T1 - Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery. T2 - Understanding the volume-outcome relationship. AU - Billingsley, Kevin. AU - Morris, Arden M.. AU - Dominitz, Jason A.. AU - Matthews, Barbara. AU - Dobie, Sharon. AU - Barlow, William. AU - Wright, George E.. AU - Baldwin, Laura Mae. PY - 2007. Y1 - 2007. N2 - Hypothesis: Although numerous studies have demonstrated an association between surgical volume and improved outcome in cancer surgery, the specific structures and mechanisms of care that are associated with volume and lead to improved outcomes remain poorly defined. We hypothesize that there are modifiable surgeon and hospital characteristics that explain observed volume-outcome relationships. Design: Retrospective cohort study. Setting: Surveillance, Epidemiology, and End Results cancer registry areas. Patients: Patients aged 66 years and older, diagnosed and surgically treated for stage I, II, or III colon ...
A two-prong approach combining ibrutinib and rituximab (Rituxin®) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical trial at The University of Texas MD Anderson Cancer Center.. Researchers presented the results today at the 54th annual meeting of the American Society of Hematology (ASH).. This is a patient population with a great need for more targeted therapies, said Jan Burger, M.D., Ph.D., associate professor in MD Andersons Department of Leukemia. Burger was lead author of the study.. Many CLL patients, especially those with indolent or non-aggressive disease, do well on the standard treatment of chemotherapy and antibodies, he said. But for a certain subset of high-risk patients, treatment often fails, and remissions, if they are achieved, are short.. According to the National Cancer Institutes Surveillance Epidemiology and End Results database, CLL is the most common type of adult leukemia in the United ...
We did a retrospective, case-only analysis of pancreatic cancer cases in the California Cancer Registry (CCR) database. The CCR is the largest contiguous-area, population-based cancer registry in the world, collecting ,130,000 new cancer cases per year in California, as described elsewhere (6, 14). The state of California legally mandated cancer reporting in 1988; standardized data collection procedures and quality control procedures have been in place ever since (15, 16). The CCR is part of the National Cancer Institutes Surveillance, Epidemiology and End Results (SEER) program. Case reporting is estimated at 98% for the entire state of California, and follow-up completion rates exceed 95% (17, 18). Because of data completeness, timeliness, and accuracy, CCR has received the highest level of certification from the North American Association of Central Cancer Registries (19). Data were abstracted from medical and laboratory records by trained tumor registrars according to Cancer Reporting in ...
Low-dose interleukin-2 and retinoic acid give unexpected 5-year survival rates for patients with advanced cancers. In a clinical trial of 500 patients with different types of stage 4 solid tumors who had responded to chemotherapy, a maintenance regimen with low-dose interleukin-2 (IL-2) and 13-cis retinoic acid (RA) has shown unexpected 5-year survival rates.. Francesco Recchia, MD, director of oncology at the Civilian Hospital in Avezzano, Italy, is scheduled to present findings from this extended phase II study in a presentation at the American Association for Cancer Research Annual Meeting 2012 in Chicago on April 2.. The open, nonrandomized trial showed substantial improvements for these patients with metastatic cancer compared with corresponding U.S. National Cancer Institute Surveillance Epidemiology and End Results (SEER) data for 5-year overall survival (OS) rates. The OS rate was 42.7% for patients in the study versus 23.3% for breast cancer patients accounted for in SEER data, and ...
The survival statistics come from the National Cancer Institutes Surveillance, Epidemiology, and End Results (SEER) database, and are based on patients who were diagnosed with esophageal cancer between 1999 and 2005.
ACPE UAN #: 0233-0000-17-003-H04-P Release Date: May 27, 2017. Expiration Date: May 27, 2020. Activity Type: Knowledge-based Credit Hours: 0.5 contact hours Activity Fee: Member: $15.00 Non-Member: $30.00 Activity Overview: What becomes possible when you link epidemiologic data to health insurance claims data? Thats one of the many innovative questions being explored at the Hutchinson Institute for Cancer Outcomes Research (HICOR). The HICOR IQ oncology informatics platform integrates cancer registry data (from the Cancer Surveillance System, part of the National Cancer Institute Surveillance, Epidemiology, and End Results [SEER] program) and enrollment and claims data from two large regional commercial insurers that cover more than 2.5 million lives. The goal is to enable performance reporting in oncology as a first step in guiding improvements that increase value in cancer care. This session will provide an overview of HICOR IQ and the related HICOR initiatives focused on promoting ...
TY - JOUR. T1 - Risk of colorectal cancer among long-term cervical cancer survivors. AU - Rodriguez, Ana. AU - Kuo, Yong Fang. AU - Goodwin, James. PY - 2014/5/1. Y1 - 2014/5/1. N2 - Because advances in therapy have increased long-term survival for women with cervical cancer, it is important to study the risk of secondary primary malignancies in high-dose organ areas. From the 1973-2009 National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, we studied the risk of developing cancer of the colon and rectum in 64,507 cervical cancer patients over 35 years after initial radiation treatment. We also assessed change in risk over time. Kaplan-Meier estimator for survival curve and Cox proportional hazards models was used. More than half (52.6%) of the cervical cancer patients received radiation treatment. In the analyses adjusted for race/ethnicity, age, marital status, surgery status, stage and grade, the risk of colon cancer between those both with and without XRT ...
The fight against cancer escalated in 1971 with the introduction of the National Cancer Act during the presidency of Richard M. Nixon. Since that time, there have been dramatic developments in a number of research areas including prevention, screening, and treatment that have had a major impact on our ability to control cancer. An integral part of the fight against cancer has been the ability to monitor the occurrence of cancer in the population and assess the impact of the introduction of advances in prevention, screening, and treatment. For more than 25 years, these functions have been performed by the SEER2 Program, which is based at the NCI in the Division of Cancer Control and Population Sciences. The purpose of this review is to briefly describe cancer surveillance at the NCI. The SEER Program is the centerpiece of these activities, with various surveillance and research functions arrayed around it to take full advantage of its potential.. The SEER Program is a sequel to two earlier NCI ...
The Incidence of Breast Cancer in the United States The National Cancer Institutes Surveillance Epidemiology and End Results Website reports that the incidence
Site-specific stage adjustments for 1973-2003 SEER Research Data (November 2005 submission). Links to stage adjustments for other data releases, plus summary staging guidance.
The lifetime risks of developing and dying from certain cancers for men and women according to the US National Cancer Institutes Surveillance Epidemiology
Privately insured people with cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two recent studies.. In one study, researchers examined data from more than 13,600 adult patients who had glioblastoma multiforme, the most common type of malignant brain tumor, between 2007 and 2012. The other study analyzed data from more than 10,200 adults who were diagnosed with testicular cancer between 2007 and 2011.. Both studies, published online in the journal Cancer in August, relied on data from the National Cancer Institutes Surveillance, Epidemiology, and End Results program. SEER tracks cancer incidence and survival in the United States.. The two cancers generally progress very differently. Glioblastoma multiforme is very aggressive; patients generally dont live much more than a year following diagnosis and the five-year survival rate is less than 5 percent. Conversely, testicular cancer responds well to chemotherapy even if it has ...
Authors: Polite BN, Lamont EB. Title: Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries.. Journal: Cancer 106(4):923-30. Date: 2006 Feb 15. Abstract: BACKGROUND: Multiple epidemiologic studies have reported associations between venous thromboembolic events and subsequent cancer diagnoses, but the published results have not suggested clear cancer screening approaches. METHODS: Using data from the National Cancer Institutes Surveillance, Epidemiology, and End Results-Medicare Program, the authors identified patients who were diagnosed with breast and colorectal carcinoma (n = 7166 patients) and compared them with a noncancer control group (n = 126,668 patients) according to their history of hospitalization for deep vein thrombosis (DVT) or pulmonary embolism (PE) in Medicare claims files over the previous 24 months. Using logistic regression analysis, the authors calculated the odds ...
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.. All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. ...
This chapter presents current estimates for cancer incidence, mortality, and survival in a large subgroup of the U.S. population based on the results of the Surveillance, Epidemiology, and End Results (SEER) Program. The SEER Program is an ongoing contract-supported program of the National Cancer Institute (NCI) that funds and coordinates the collection of cancer data in population-based cancer registries located throughout the United States. These registries, although not randomly selected, are thought to be reasonably representative of the U.S. population; a number of the registries cover diverse populations of particular epidemiologic interest. The program publishes incidence, mortality, and survival data annually. ...
Many five-year survival rates increased among both blacks and whites, but racial disparities have increased in prostate cancer and female breast cancer. We still have a lot of work to do to understand the causes of these differences, but certainly differences in the kinds and timing of recommended treatments are likely to play a role, said Dr. Lynne Penberthy, associate director of the U.S. National Cancer Institutes Surveillance Research Program ...
Many five-year survival rates increased among both blacks and whites, but racial disparities have increased in prostate cancer and female breast cancer. We still have a lot of work to do to understand the causes of these differences, but certainly differences in the kinds and timing of recommended treatments are likely to play a role, said Dr. Lynne Penberthy, associate director of the U.S. National Cancer Institutes Surveillance Research Program ...
Many five-year survival rates increased among both blacks and whites, but racial disparities have increased in prostate cancer and female breast cancer. We still have a lot of work to do to understand the causes of these differences, but certainly differences in the kinds and timing of recommended treatments are likely to play a role, said Dr. Lynne Penberthy, associate director of the U.S. National Cancer Institutes Surveillance Research Program ...
Men with prostate cancer treated with external beam radiation have a 70% higher risk of developing rectal cancer than men who have surgery, a US study has found. Radiation is now used for about 17% of patients with prostate cancer.. The retrospective population based study used data from the US National Cancer Institutes surveillance, epidemiology, and end results (SEER) register, from 1973 to 1994, and included more than 85 000 men aged 18 to 80. The participants had had invasive microscopically confirmed prostate cancer but no evidence of … ...
Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015 Sep; 22(9):2965-71 ...
A premier source for United States cancer statistics, SEER gathers information related to incidence, prevalence, and survival from specific geographic areas that represent 28 percent of the population, as well as compiles related reports and reports on the national cancer mortality rates. Their aim is to provide information related to cancer statistics and decrease the burden of cancer in the national population. SEER has been collecting data from cancer cases since 1973 ...
Fort Bend County HHS is excited that the pause, and research that followed, allowed the CDC and FDA to confirm the safety of the Johnson & Johnson vaccine. This research found that there were only about two cases of the rare clotting disorder were found per every one million doses of Johnson and Johnson vaccine administered. We are committed to providing safe and effective vaccines that will permit our community to return to the activities we have been missing.. Many residents have been waiting for this vaccine to return to distribution. The CDC estimates that using the Johnson and Johnson vaccine in the United States will prevent more than 2,200 ICU admissions and 1,400 deaths in the next six months. Consequently we will make our supply of the Johnson and Johnson vaccines available to the public. As with all vaccines, we will make sure those who receive the Johnson & Johnson vaccine are aware of the risks and benefits. The majority of the vaccine Fort Bend County receives and administers is ...
Information about the 2019 coronavirus, or COVID‑19, including Maine CDCs response and resources for Maine people and health providers.
This retrospective cohort study using the Surveillance, Epidemiology, and End Results registry reports that there has been a significant increase in the inciden
The Stanford Cancer Center provides the full spectrum of cancer services, from diagnosis to the newest, most effective treatments and ongoing support for cancer survivors.. More about Adult Care ...
Anyone newly diagnosed with prostate cancer rated Gleason 6 (and usually Gleason 7) has all treatment options available to him and, since this cncer is considered low risk, he has time to decide which choice is best for him. So, the first thing a new prostate cancer patient should do is to do research on the available options before he actually has to make the decision regarding which treatment to choose.. The following is my response to other men who asked for similiar advice about the treatment choices avilable to them. Its a summary of the available treatment options and my personal opinion on the matter. You can, of course, ignore my opinion about which treatment choice I think is best. The overview of the choices is still otherwise valid.. Choices You Need To Consider: . . . People here know me as an outspoken advocate for CK and against surgery of any kind. I was treated w/CK 7 years ago (Gleason 6 and PSA less than 10). You can troll the forum for my many comments on this point. Here ...
Anyone newly diagnosed with prostate cancer rated Gleason 6 (and usually Gleason 7) has all treatment options available to him and, since this cncer is considered low risk, he has time to decide which choice is best for him. So, the first thing a new prostate cancer patient should do is to do research on the available options before he actually has to make the decision regarding which treatment to choose.. The following is my response to other men who asked for similiar advice about the treatment choices avilable to them. Its a summary of the available treatment options and my personal opinion on the matter. You can, of course, ignore my opinion about which treatment choice I think is best. The overview of the choices is still otherwise valid.. Choices You Need To Consider: . . . People here know me as an outspoken advocate for CK and against surgery of any kind. I was treated w/CK 7 years ago (Gleason 6 and PSA less than 10). You can troll the forum for my many comments on this point. Here ...
A system and method that includes providing a query platform with a normalized query tool and a collection interface presenting result items of a collection; adding result items produced by the query tool to a collection, wherein adding a result item to the collection comprising: receiving a query input in a query syntax normalized across multiple query services, retrieving result data of the first query input through a service provider application programming interface (API), processing the result data into result data with at least one context parameter, rendering the result data into a result item, and adding the result item to the collection; and adding at least a second result item to the collection, wherein the second result card is retrieved from a second external service provider API according to the context parameter.
I did a pet scan to check an enlarged thymus gland post thyroid cancer. Results I got today say diffuse thymic FDG activity with SUV max of 2.9. What does this mean? Should cancer be suspected?
Acute Myeloid Leukemia is an extremely difficult cancer to treat but recently a better understanding of this stubborn disease and advancements in treating it have brought more hope and a renewed feeling of optimism to the Acute Myeloid Leukemia community. Guest Dr. Jessica Altman brings us up to speed on the new treatments and new approaches to treating AML.. For more information on AML, visit out AML resource page.. ...
Would anyone be able to help me understand these results. I have got conflicting answers. Any help would be appreciated. 2. Cervix, 6-oclock (biopsy): Microscopic foci of invasive squamous cell ca...
Because the various standard-setting organizations use their data for different purposes, some data elements had different meanings, depending on the organization using the data. A long history of cooperation has been evident among organizations interested in cancer data to resolve the discrepancies between organizations in their interpretation of data elements.. The earliest standard setters were CoC and SEER. The End Results Group, predecessor of SEER, published coding rules and guidelines as early as the 1950s; CoC published its first data collection manual, the Supplement on the Tumor Registry, in conjunction with its Cancer Program Manual 1981. At that time, hospital-based cancer registries often used CoCs recommended codes and coding rules, and SEER central registries used those of the SEER Program. The two systems were not always in agreement. As a result, CoC and SEER began working together in the early 1980s to make the codes and definitions in their manuals consistent. CoC and SEER ...
yes definitely how i took it in quaters i didnt get such a strong and heavy peak by doing this, i would also think that the environment that i was in impacted my peak/mood as well (fights people being rude and violent) getting a near miss to the head :/, kinda of put me in more of a fight or fly mode and definitely changed/increased/decreased cognitive balances/effects which would all have a factor to the experience October 1, 2016, 9:27 am GMT ...
Are you wanting to set up a decompilation related company? He is a partial list of the URLs. RED Warning: URLs in italics could lock up your browser for at least 2 ...
This trial assessed the efficacy and safety of sorafenib in advanced hepatocellular carcinoma patients in SEER-Medicare Database. The study determined the
Our objective was to assess racial differences in the 5-year relative survival rates (RSRs) of Cervical Cancer (CerCancer) by stage at diagnosis, between Black and White women, living in Alabama, USA. Data for 3484 Blacks and 21,059 Whites diagnosed with CerCancer were extracted from the 2004 to 2013 Surveillance, Epidemiology, and End Results (SEER) database. We incorporated age groups, CerCancer stages, county, and year of diagnosis to compare the RSR between Blacks and Whites, using SEER*Stat software. In urban, Black Belt (BB) and other rural counties, Whites diagnosed with localized stage of CerCancer always had better chances of survival because their RSRs were always more than 77%, compared to Blacks. Only exception was in Blacks living in other rural counties, who had a significantly higher RSR of 83.8% (95% Cl, 74.2-90.1). Which was the same as in Whites (83.8% (95% CI 74.5-89.9) living in BBC. Although, in other rural counties, Whites had a slightly lower RSR of 83.7% (95% CI 79.9-86.8%),
Disease Surveillance Epidemiology Programs primary purpose is to study the distribution and determinants of notifiable Disease Surveillances
According to the American Journal of Clinical Nutrition, which is published by The American Society for Nutrition, research conducted by the Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm (SCL and AW), and the Department of Surgery and the Center for Clinical Research, Uppsala University, Central Hospital, Västerås, Sweden (LB) found that women who consumed high intakes of four servings or more per day of dairy products (about 32 ounces of milk) had twice the risk of ovarian cancer than women who consumed less than two servings per day. According to the U.S. National Institute of Healths National Cancer Institutes Surveillance Epidemiology and End Results (SEER) report the ovarian cancer rate for women in 2003 was 13.2 per 100,000 (or 0.0132%). Thus, doubling ones risk would go from 0.0132% to 0.0264% (or a total increased risk of 13/1000 of a percent). Of course, this all assumes the 0.0132% was a baseline ovarian ...
BACKGROUND: Despite advancements in the treatment of childhood leukemia, socioeconomic status (SES) may potentially affect disease prognosis. This study aims to evaluate whether SES is associated with survival from childhood leukemia.. METHODS: The US National Cancer Institute Surveillance, Epidemiology and End Results Program (SEER) 1973-2010 data were analyzed; thereafter, results were meta-analyzed along with those from survival (cohort) studies examining the association between SES indices and survival from childhood leukemia (end-of-search date: 31 March 2014). Random-effects models were used to calculate pooled effect estimates (relative risks, RRs); meta-regression was also used.. RESULTS: We included 29 studies yielding 28 804 acute lymphoblastic leukemia (ALL), 3208 acute myeloblastic leukemia (AML) and 27 650 any leukemia (denoting joint reporting of all subtypes) cases. According to individual-level composite SES indices, children from low SES suffered from nearly twofold higher ...
WEDNESDAY, Feb. 24, 2021 (HealthDay News) -- Protective immune system antibodies that develop after being infected with COVID-19 last for at least a few months, a new study suggests. And reinfection does seem to be relatively rare.. That could have big implications for public health and societies, including allowing people to return to physical workplaces and go to school, the researchers said.. The data from this study suggest that people who have a positive result from a commercial antibody test appear to have substantial immunity to SARS-CoV-2, which means they may be at lower risk for future infection, researcher Dr. Lynne Penberthy, the associate director of the U.S. National Cancer Institutes Surveillance Research Program, said in an institute news release.. Additional research is needed to understand how long this protection lasts, who may have limited protection, and how patient characteristics, such as comorbid conditions [other illnesses], may impact protection. We are nevertheless ...
Authors: Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA. Title: Hematopoietic malignancies associated with viral and alcoholic hepatitis.. Journal: Cancer Epidemiol Biomarkers Prev 17(11):3069-75. Date: 2008 Nov. Abstract: Hepatitis C virus (HCV) and hepatitis B virus (HBV) have been associated with hematopoietic malignancies, but data for many subtypes are limited. From the U.S. Surveillance, Epidemiology, and End Results-Medicare database, we selected 61,464 cases (> or = 67 years) with hematopoietic malignancies and 122,531 population-based controls, frequency-matched by gender, age, and year (1993--2002). Logistic regression was used to compare the prevalence of HCV, HBV, and alcoholic hepatitis in cases and controls, adjusted for matching factors, race, duration of Medicare coverage, and number of physician claims. HCV, HBV, and alcoholic hepatitis were reported in 195 (0.3%), 111 (0.2%), and 404 (0.7%) cases and 264 (0.2%), ...
Neuroendocrine carcinoma (NEC) of the breast is a rare type of carcinoma that has not been well studied or characterized. Of the limited number of studies reported in the literature, most are case reports. A few small retrospective series studies have been reported. We reviewed data on 142 cases of mammary NEC recorded in the surveillance, epidemiology, and end results (SEER) database during 2003-2009 and evaluated disease incidence and patient age, sex, and race/ethnicity; clinicopathologic characteristics; and survival in comparison to invasive mammary carcinoma, not otherwise specified. We also performed univariate and multivariate analyses to identify prognostic factors in this disease. Review of the 142 SEER cases revealed that NEC is an aggressive variant of invasive mammary carcinoma. It generally occurred in older women (|60 years); present with larger tumor size (|20 mm), higher histologic grade, and higher clinical stage; and result in shorter overall survival and disease-specific survival
|i|Objective|/i|. To examine the distribution of stage at diagnosis for 12 cancers in Kuwait, to estimate stage-specific net survival at 1 and 5 years after diagnosis, and to assess differences in stage-specific survival between Kuwait and the United States. |i|Material and Methods|/i|. Data were obtained from the Kuwait Cancer Registry, for Kuwaiti patients diagnosed during 2000–2013, with follow-up to 31 December 2015. The distribution of Surveillance Epidemiology and End Results (SEER) Summary Stage for 12 malignancies was examined. We estimated net survival by stage up to 5 years after diagnosis, controlling for background mortality with life tables of all-cause mortality in the general population by single year of age, sex, and calendar period. Survival estimates were age-standardised using the International Cancer Survival Standard (ICSS) weights. |i|Results|/i|. Only 14.2% of patients were diagnosed at a localised stage and 38.9% at the regional stage. The
Real-World Treatment Patterns and Outcomes among Elderly Acute Myeloid Leukemia Patients in the United States. By Sacha Satram- Hoang, Carolina Reyes, Deborah Hurst, Khang Q. Hoang and Bruno C. Medeiros. Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older. Using the linked SEER-Medicare database, we conducted a retrospective cohort analysis to examine patient characteristics, treatment patterns, and survival among the elderly AML patients in routine clinical practice. Out of 29,857 patients with AML in the database, 8336 were eligible for inclusion in the study. The inclusion criteria included a diagnosis with first primary AML between January 1, 2000 and December 31, 2009, ,66 years of age, and continuous enrollment in Medicare Parts A and B in the year before diagnosis. Forty percent (N = 3327) of the cohort received chemotherapy within 3 months after diagnosis. The multivariable overall survival analyses showed a lower risk of death among those receiving ...
FRIDAY, Oct. 2, 2020 (HealthDay News) - There is a threefold higher risk for dying of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to a study published online Sept. 16 in JAMA Network Open.. Vasily Giannakeas, M.P.H., from University of Toronto, and colleagues used the Surveillance, Epidemiology and End Results (SEER) database to identify 144,524 women who had a first primary DCIS diagnosis between 1995 and 2014. Women were followed through March 2020 to identify risk for dying of breast cancer.. The researchers found 1,540 deaths from breast cancer in the cohort. Using the SEER-based incidence and case-fatality rates, 458 breast cancer deaths would have been expected in the general population. Among women with DCIS, the standardized mortality ratio for death from breast cancer was 3.36. More than 15 years after diagnosis, the elevated risk for death persisted.. This suggests that our current treatment focus on preventing invasive recurrence is insufficient to ...
A summary of the article is shown below:. OBJECTIVES: The incidence of depression after a late-stage cancer diagnosis is poorly understood and has not been the subject of intense investigation. We used population-based data to examine trends in postdiagnosis depression incidence among racial/ethnic and sexual groups.METHODS: We identified 123,066 patients diagnosed with late-stage breast, prostate, lung, or colorectal cancer from 2001 to 2013 in the Surveillance Epidemiology and End Results Medicare-linked database. The primary outcome was the incidence of postdiagnosis depression after a late-stage cancer diagnosis. Trend analysis was performed using the Cochran-Armitage test. Stratified incidence rates were calculated for the racial/ethnic and sexual groups.RESULTS: The incidence of depression after cancer diagnosis increased from 15.3% in 2001 to 24.1% in 2013, P ...
We hypothesized that breast cancer (BCa) patients in urban counties would have higher rates of post-lumpectomy radiation therapy (RT) relative to patients in near-metro and rural counties. We used the Surveillance, Epidemiology, and End Results (SEER) database to identify women diagnosed with BCa tr …
This phase II trial studies how well epacadostat and pembrolizumab work in treating patients with gastroesophageal junction or gastric cancer that has spread to other parts of the body and cannot be removed by surgery. Epacadostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Giving epacadostat and pembrolizumab may work better in treating patients with gastroesophageal junction or gastric cancer. Stanford is currently accepting patients for this trial.. ...
Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ ...
We know its a worrying time for people with cancer. Please read our information about coronavirus and cancer alongside this page. If you have symptoms of cancer you should still contact your doctor and go to any appointments you have. Spotting cancer early means treatment is more likely to be successful.. Read about coronavirus and cancer. ...
A Pap smear every two years offers the best chance of preventing cervical cancer. Read our fact sheet on symptoms, screening and risk.
Source: Incidence data provided by the SEER Program and the National Program of Cancer Registries SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2019 submission). Rates calculated by the National Cancer Institute using SEER*Stat. Rates are age-adjusted to the 2000 US standard population (19 age groups ...
Source: Incidence data provided by the SEER Program and the National Program of Cancer Registries SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2019 submission). Rates calculated by the National Cancer Institute using SEER*Stat. Rates are age-adjusted to the 2000 US standard population (19 age groups ...
BACKGROUND The American Joint Committee on Cancers (AJCC) 7th edition cancer staging manual reflects recent changes in cancer care practices. This report assesses changes from the AJCC 6th to the AJCC 7th edition stage distributions and the quality of site-specific factors (SSFs). METHODS Incidence data for renal parenchyma and pelvis and ureter cancers from 18 Surveillance, Epidemiology, and End Results (SEER) registries were examined, including staging trends during 2004-2010, stage distribution changes between the AJCC 6th and 7th editions, and SSF completeness for cases diagnosed in 2010. RESULTS From 2004 to 2010, the percentage of stage I renal parenchyma cancers increased from 50% to 58%, whereas stage IV and unknown stage cases decreased (18% to 15%, and 10% to 6%, respectively). During this period, the percentage of stage 0a renal pelvis and ureter cancers increased from 21% to 25%, and stage IV and unknown stage tumors decreased (20% to 18%, and 7% to 5%, respectively). Stage ...
The National Cancer Institutes (NCI) report Surveillance Epidemiology and End Results (SEER) provides a wealth of data regarding thyroid cancer, including median age at diagnosis and prevalence.
The aim of the present study was to examine the epidemiology, natural history, treatment and long-term survival of patients with adenosquamous cell carcinoma of the prostate. The Surveillance, Epidemiology, and End Results (SEER) Program database was used ...
An apparatus includes packed data registers and an execution unit. An instruction is to indicate a first source packed data that is to include a first packed data elements, a second source packed data that is to include a second packed data elements, and a destination storage location. The execution unit, in response to the instruction, is to store a packed data result that is to include packed result data elements in the destination storage location. Each of the result data elements is to correspond to a different one of the data elements of the second source packed data. Each of the result data elements is to include a multiple bit comparison mask that is to include a different comparison mask bit for each different corresponding data element of the first source packed data compared with the corresponding data element of the second source packed data.
56 Cancers originate due to the accumulation of multiple mutations. The mechanism causing this, particularly in the case of epithelial cancers, or carcinomas, has not been clearly determined. Epidemiological studies indicate that environmental and lifestyle factors can account for most carcinomas, but do not point to a specific mechanism. Some models for human carcinogenesis suggest that the accumulation of four to six somatic mutations drives the neoplastic transformation. The number of mutations, four to six, is based almost exclusively on the analysis of age-specific incidence data. Several anomalies exist with the age-specific incidence data. For instance, breast carcinoma incidence data does not follow this model. (This has been explained by suggesting that breast tissue ages at a different rate than calendar time.) Prostate carcinoma incidence increases more rapidly with age than most others, implying that 15 to 20 mutations are required. Hence, one approach to better understand epithelial ...
Over the years, the age-adjusted incidence rate due to invasive cancer has continued to decline for NJ males but has remained fairly steady for NJ females. In the total NJ population and among each racial/ethnic group, males have higher incidence rates compared to females. The age-adjusted incidence rate of total invasive cancer among NJ Black males, which has historically ranked highest for decades, is now trending below White males in recent years. For recent years, county incidence rates range from a low of 389 per 100,000 population in Hudson County to a high of 544 per 100,000 population in Gloucester County ...
The end result of mitosis is two identical daughter cells. These daughter cells are also identical to the parent cell. Mitosis is essential for growth and repair in living...
comorbidity definition: the clear presence of several conditions (or conditions) as well as a primary illness or condition.; the end result of these extra problems or conditions.; The presence of more…
Most cancers dont develop overnight or out of nowhere,It develop base on our lifestyle,what we drink,what we eat,what we do in our health,what we take.cancer is highly predictable, the end result of a decade-long process,but just a few simple changes in your daily life can significan ...